* BPS 2006 Meeting *


As a Guest Society of Experimental Biology ’06, the Behavioral Pharmacology Society held its annual scientific meeting on Saturday 01 April 2006 at the San Francisco Marriott and Marina (55 Fourth Street) in San Francisco, CA. The meeting consisted of a reception and dinner on Friday evening (31 March) and an all-day scientific session on Saturday (1 April).

The program of scientific talks was as follows:

  • 7:30AM - Breakfast, time for speakers to load and preview talks.

  • 7:55AM - Charles France, University of Texas Health Science Center at San Antonio, BPS President, Welcome and opening remarks.

  • 8:00AM - Klaus A. Miczek, Tufts University, "Social stress: resolving the paradox of anhedonia and a cocaine binge."

  • 8:30AM - Stephen C. Fowler, Herb Covington, and Klaus A. Miczek, University of Kansas and Tufts University, "Emerging motor routines during 24-hr cocaine self-administration binges in rats."

  • 9:00AM - Greg Collins, Holden Ko, Chad Galuska, Micky Koffarnus, and Jim Woods, University of Michigan, "Dopamine agonists and antagonists in rats and monkeys."

  • 9:30AM - Break

  • 9:45AM through lunch - Minisymposium: Constitutive Activity and Inverse Agonism

  • 9:45AM - S. Stevens Negus, Harvard University, "Some implications of receptor theory for in vivo assessment of inverse agonists."

  • 10:15AM - Alice M. Young, Scott E. Bowen, and Marianne Evola, Texas Tech University and Wayne State University, "Can opioid antagonists function as inverse agonists?"

  • 10:45AM - Ellen A. Walker, Temple University "Behavioral pharmacology of purported 5-HT2C inverse agonists."

  • 11:15AM - John A. Harvey and Vincent J. Aloyo, Drexel University, "The serotonin 5-HT2A receptor: inverse agonism and receptor regulation."

  • 11:45AM - Bill Clarke, University of Texas Health Science Center at San Antonio, "Discussion of minisymposium."

  • 12:15PM - Lunch

  • 1:15PM - Richard J. Lamb, University of Texas Health Science Center at San Antonio, "Shaping smoking cessation and reductions in smokers without plans to quit."

  • 1:45PM - Meg Haney, Columbia University, "Influence of opioid antagonists on cannabinoid effects in humans."

  • 2:15PM - Sandra D. Comer, Maria A. Sullivan, Ellen A. Walker and Suzanne K. Vosburg, New York State Psychiatric Institute and Columbia University, "Comparative pharmacology of fentanyl, oxycodone, morphine, buprenorphine and heroin in morphine-maintained human research volunteers."

  • 2:45PM - Gerry Herrera, MED Associates, Inc., "Mapping the gastrointestinal tract: novel imaging techniques reveal patterns in gut motility. "

  • 3:15PM - Break

  • 3:30PM - Wouter Koek and Charles P. France, University of Texas Health Science Center at San Antonio, "Gamma-hydroxybutyrate (GHB) and baclofen: differential antagonism by the GABAB receptor antagonist CGP35348."

  • 4:00PM - Cameron L. Noland, Bettye L. Campbell, and Jonathan L. Katz, Intramural Research Program, National Institute on Drug Abuse, NIH, "The effects of experimental history on the substitution of D1-like and D2-like agonists in rats trained to discriminate cocaine from saline."

  • 4:30PM - Susan Wood, University of Michigan, "Stress and fainting in rats."

  • 5:00PM - Nurith Amitai, Svetlana Semenova, and Athina Markou, The Scripps Research Institute and University of California at San Diego, "Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotics."

  • 5:30PM - Wrap-up and adjourn






BPS acknowledges the generous contributions of:

Med Associates, Inc. ,

Porsolt & Partners Pharmacology

Merck & Co., Inc.,

and Wyeth Pharmaceuticals



Last updated 28 April 06